 |
|
|
|
 |
|
|
 Print version |  PDF version |  Send article |  RSS-Feed
ActivBiotics' Intellectual Property Assets, Including Drug Product Candidates, Sold for $3.5 Million07 Apr 2008 -
Joseph F. Finn, Jr., CPA, the Assignee for the Benefit of Creditors of ActivBiotics, announced the completion of the sale of ActivBiotics intellectual property assets for $3.5 million. The assets consisted of 1) Rifalazil, a Phase II antibiotic, 2) a library of novel rifamycin compounds, and 3) a clinical stage superoxide dismutase mimetic (SODm) and a library of SODm small molecules.
The sale of the assets was conducted through an Assignment for the Benefit of Creditors. This process entails transference of the assets to a fiduciary who then liquidates them for the benefit of the creditors of the company.
Additional information
ActivBiotics Inc.
Lexington, MA, United States of America
News
|
|
|
|
|
|
Top